Status:

COMPLETED

Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol

Lead Sponsor:

Bio-Rad Laboratories

Collaborating Sponsors:

American National Red Cross

Centers for Disease Control and Prevention

Conditions:

Mass Screening

Eligibility:

All Genders

16+ years

Brief Summary

The purpose of the study is to screen blood donors for the presence of NS1 antigen of the dengue virus at the American Red Cross in Puerto Rico region (and Monroe County, Florida) using the Platelia D...

Detailed Description

Dengue is an endemic disease that is increasingly more common in tropical climates and the dengue epidemic in Puerto Rico (May 2009) presents a risk to the blood supply in Puerto Rico. Also, on July 1...

Eligibility Criteria

Inclusion

  • The Puerto Rico Region and Monroe County, Florida will maintain a log of all blood donors enrolled by collection date documenting the time of collection, centrifugation and freezing; only centrifuged and frozen PPTs will be sent to the Charlotte NTL for NS1 Ag testing. Samples frozen when received at the Charlotte NTL will be tested. Samples that arrive thawed will be tested if the time unfrozen is 24 hours or less. When necessary, alternate PPTs (surplus samples used for NAT) will be used for dengue NS1 Ag testing; a log will be kept by the Charlotte NTL documenting the sample identification numbers of thawed samples, approximate time unfrozen and the samples that require an alternate PPT for dengue NS1 Ag testing.

Exclusion

  • Samples that are deemed unacceptable for testing include those held for excessive storage times when thawed (in excess of 24 hours unfrozen or otherwise as determined by the Principal Investigator) or that are cracked or otherwise damaged. Samples having inadequate volume for initial and repeat testing in duplicate will not be tested as determined by the Charlotte NTL; a log will be kept of samples unacceptable for testing and the reason that the samples are unsuitable for testing.

Key Trial Info

Start Date :

March 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2012

Estimated Enrollment :

182353 Patients enrolled

Trial Details

Trial ID

NCT01226173

Start Date

March 1 2010

End Date

August 1 2012

Last Update

September 24 2012

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Community Blood Centers of Florida, Inc.

Lauderhill, Florida, United States, 33313

2

American Red Cross

San Juan, Puerto Rico, 00936